Dexcom Introduces AI-Powered Reports for Stelo Glucose Monitor, Offering Personalized Insights

/in /tarafından

Dexcom has launched a new artificial intelligence feature for its Stelo continuous glucose monitor (CGM), giving users a more personalized view of how their meals, sleep, and activities affect their glucose levels. This AI-driven addition, which debuted on Tuesday, is part of Dexcom’s broader efforts to enhance user engagement and provide deeper insights into glucose management.

Stelo, an over-the-counter CGM that monitors real-time blood sugar levels by inserting a small sensor under the skin, was first introduced in August. Unlike traditional CGMs, Stelo is designed for adults who do not take insulin, opening up a new consumer market for the company. This latest feature aims to make Stelo more valuable and personalized for everyday users, with Dexcom focusing on enhancing its capabilities for a broader audience.

Jake Leach, Dexcom’s chief operating officer, emphasized that user feedback had driven the company’s decision to integrate more advanced AI features. “The No. 1 feedback we get is users want to see more,” Leach explained in an interview with CNBC. “They’re making an investment and wearing the product, and they want to be able to take the most advantage of all the data that they’re generating.” The new AI-generated reports reflect this need for deeper, actionable insights.

Dexcom is leveraging Google Cloud’s Vertex AI platform and its Gemini models to build the new AI features. These tools enable developers to synthesize diverse data types, a complex task in healthcare. The company is proceeding cautiously, ensuring the AI platform adds value without compromising the reliability of its core CGM products, which are essential for managing serious health conditions.

While Stelo users have always had access to weekly insights reports, these reports were traditionally formatted in a standard template. The new AI-powered version promises to offer a more personalized experience, drawing on individual user data to provide tailored feedback. For example, if a user’s activity level is low after meals, the report will include specific recommendations to help improve glucose management.

It is important to note that while the AI feature offers personalized insights, it does not provide medical advice. Dexcom has developed the feature with guidance from the U.S. Food and Drug Administration’s (FDA) AI framework. The FDA approved Stelo for use in March, and the company is now looking at expanding the use of generative AI across its other CGM products.

Looking forward, Dexcom plans to evolve its AI capabilities to provide real-time feedback rather than just weekly summaries. The company also envisions using the AI platform to predict potential issues before they arise, much like a “check engine light” in a car, providing early warnings and suggestions for further consultation with healthcare providers.

Chris Sakalosky, vice president of strategic industries at Google Cloud, noted the potential for the technology to offer predictive insights. “It gives you a sense for what could be going on, and recommendations of where you might want to go to seek more advice,” Sakalosky said.

The updated AI-powered reports are already rolling out to Stelo users this week, marking an important step in Dexcom’s mission to make glucose monitoring more intuitive and informative for consumers.

 

Jared Isaacman: Trump’s NASA Pick and a Crypto Billionaire with Space Ambitions

/in /tarafından

Jared Isaacman, President-elect Donald Trump’s pick to lead NASA, is not only a space enthusiast but also a crypto billionaire with significant influence in the fintech sector. At 41 years old, Isaacman made headlines earlier this year by commanding the world’s first all-civilian space mission, a remarkable feat in commercial space travel. He is also the founder and CEO of Shift4, a fintech company specializing in secure payment processing, which he founded at the age of 16 in 1999. The company, which went public in 2020, has seen its stock surge nearly 40% this year, bringing its market value to $9.3 billion.

Trump highlighted Isaacman’s leadership in a post on Truth Social, praising him for his success in building Shift4 into a global financial technology leader. Much of that success stems from Isaacman’s forward-thinking approach to cryptocurrency, particularly his investments in stablecoins—a less glamorous but growing sector of the digital asset market.

In early 2022, Isaacman and his team met with crypto entrepreneurs Alex Wilson and Pat Duffy, who were in the process of selling their crypto donation platform, The Giving Block, to Shift4. The group discussed the potential applications of blockchain technology across Shift4’s payment services. While the broader crypto market was booming, with digital assets like Bitcoin reaching record highs, Isaacman and his team focused on stablecoins—cryptocurrencies pegged to the value of real-world assets, typically the U.S. dollar.

Stablecoins, worth approximately $200 billion today, are seen as a more stable and practical option for cross-border payments, offering lower transaction costs and faster processing times compared to traditional financial systems. Isaacman, Wilson, and Duffy believed that stablecoins were more likely to become mainstream as a payment method than Bitcoin or Ethereum. This vision led to Shift4’s acquisition of The Giving Block for $54 million, along with a potential earnout of up to $246 million. In October 2023, Shift4 rolled out its “Pay with Crypto” service, allowing customers to use cryptocurrency at over 200,000 merchants.

Isaacman’s involvement in the crypto space aligns with the broader trend of digital currencies becoming increasingly mainstream. The crypto market has seen substantial growth since Trump’s election win in 2024, with Bitcoin reaching new highs and institutional investors jumping in, fueled by the popularity of spot bitcoin exchange-traded funds. Companies like Stripe, PayPal, Visa, and Mastercard are also embracing stablecoins, recognizing their potential for faster and cheaper transactions.

In addition to his achievements in fintech, Isaacman has also pursued a passion for space exploration. He has commanded two private SpaceX missions, one in 2021 and another in 2024, further cementing his ties with Elon Musk, a key ally of Trump. Isaacman views his appointment to lead NASA as an opportunity to advance human space exploration and contribute to humanity’s understanding of the universe.

Despite his new role, Isaacman will remain CEO of Shift4 until his Senate confirmation. He expressed that his choice to lead NASA is driven by his desire to give back to the country that enabled his success and to continue pushing the boundaries of space exploration. His leadership at both Shift4 and NASA is expected to shape the future of space technology and cryptocurrency as they continue to converge.

 

Suki Expands Collaboration with Google Cloud to Enhance AI Tools for Clinicians

/in /tarafından

Health-tech startup Suki has announced an expanded partnership with Google Cloud, focusing on broadening its range of assistive tools for healthcare professionals. The collaboration leverages Google Cloud’s Vertex AI platform, which enables the development and deployment of advanced AI models. With this new integration, Suki aims to go beyond clinical documentation to offer tools that support clinicians in managing patient data more efficiently.

Suki’s flagship product, the Suki Assistant, helps physicians by automatically converting patient visit recordings into clinical notes, thus relieving them of the time-consuming task of manual documentation. The enhanced partnership with Google Cloud introduces two new features—patient summarization and a Q&A tool—designed to further assist clinicians in providing care.

The patient summary feature will allow doctors to access essential patient information, such as age, medical history, chronic conditions, and recent prescriptions, with a single click. By consolidating this information in one place, the feature aims to save clinicians the 15 to 30 minutes they typically spend searching for these details. Additionally, Suki’s new Q&A tool will allow doctors to ask specific questions about a patient’s health, such as querying their latest lab results or vaccination history. This tool uses AI to provide quick, accurate answers, improving efficiency and enabling healthcare providers to focus more on patient care.

The new features are expected to be available to a select group of clinicians starting today, with general availability anticipated for early next year. Importantly, these updates will not incur additional costs for existing customers.

Suki’s CEO, Punit Soni, emphasized that the company’s vision has always been to create a comprehensive assistant for clinicians, not just a documentation tool. He added that Suki’s innovations reflect a broader trend in healthcare, where AI is increasingly being integrated into clinical workflows to reduce administrative burdens. Soni, who previously worked at Google, stated that AI’s role in healthcare is poised for significant growth, much like the internet’s transformative impact on business and communication.

The company, which is already used by 350 health systems and clinics across the U.S., has seen rapid growth, tripling its client base this year. As healthcare systems continue to face challenges related to burnout and administrative overload, AI tools like Suki’s could become essential in easing the workload for doctors and improving overall efficiency in the healthcare sector.

Suki recently raised $70 million in funding, highlighting the growing interest from investors in healthcare AI solutions. With competition intensifying, including from companies like Microsoft’s Nuance Communications, which also provides AI-powered documentation tools, Suki’s ability to innovate with these new features will be crucial in maintaining its competitive edge.